Welcome to LookChem.com Sign In|Join Free

CAS

  • or

132213-03-7

Post Buying Request

132213-03-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

132213-03-7 Usage

General Description

IMIDAZO[1,2-A]PYRIDIN-6-YLMETHYLAMINE, also known as IPAM, is a chemical compound with the molecular formula C9H10N4. It is primarily used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. IPAM has a heterocyclic structure containing an imidazole ring fused to a pyridine ring, with a methylamine group attached to the sixth carbon of the pyridine ring. It is a versatile building block in organic chemistry and can undergo various reactions to form a wide range of derivative compounds. IPAM is a valuable tool for medicinal chemists and drug discovery researchers due to its potential for creating novel bioactive molecules. It is also used in the synthesis of ligands for metal-catalyzed cross-coupling reactions and as a precursor in the preparation of functionalized heterocycles.

Check Digit Verification of cas no

The CAS Registry Mumber 132213-03-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,2,1 and 3 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 132213-03:
(8*1)+(7*3)+(6*2)+(5*2)+(4*1)+(3*3)+(2*0)+(1*3)=67
67 % 10 = 7
So 132213-03-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H9N3/c9-5-7-1-2-8-10-3-4-11(8)6-7/h1-4,6H,5,9H2

132213-03-7Relevant articles and documents

MASP-2 INHIBITORS AND METHODS OF USE

-

Paragraph 0305-0306; 0503-0504, (2021/06/11)

The present disclosure provides, inter alia, compounds with MASP-2 inhibitory activity, compositions of such compounds, and methods of making and using such compounds.

Discovery of (S)-1-(1-(Imidazo[1,2- a ]pyridin-6-yl)ethyl)-6-(1-methyl-1 H -pyrazol-4-yl)-1 H -[1,2,3]triazolo[4,5- b ]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer

Jia, Hong,Dai, Guangxiu,Weng, Jianyang,Zhang, Zhulin,Wang, Qing,Zhou, Feng,Jiao, Longxian,Cui, Yumin,Ren, Yongxin,Fan, Shiming,Zhou, Jinghong,Qing, Weiguo,Gu, Yi,Wang, Jian,Sai, Yang,Su, Weiguo

supporting information, p. 7577 - 7589 (2014/12/11)

HGF/c-Met signaling has been implicated in human cancers. Herein we describe the invention of a series of novel triazolopyrazine c-Met inhibitors. The structure-activity relationship of these compounds was investigated, leading to the identification of compound 28, which demonstrated favorable pharmacokinetic properties in mice and good antitumor activities in the human glioma xenograft model in athymic nude mice.

The photosolvolysis of N-arylmethyladenines. Photoremovable N-arylmethyl protective groups for N-containing compounds

Er-Rhaimini, A.,Mohsinaly, N.,Mornet, R.

, p. 5757 - 5760 (2007/10/02)

N-arylmethyladenines are photolyzed in water, giving adenine and the corresponding arylmethanols.The reaction is not only observed when the arylmethyl group is a metasubstituted benzyl, but also with more complex substituents like imidazopyridin-6-ylmethyl.Meta-substituted arylmethyl groups are proposed as photoremovable N-protective groups in adenine chemistry.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 132213-03-7